BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33728572)

  • 41. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
    Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
    Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
    Devesa A; Camblor Blasco A; Pello Lázaro AM; Askari E; Lapeña G; Gómez Talavera S; Taibo Urquía M; Rodríguez Olleros C; Tuñón J; Ibáñez B; Aceña Á
    ESC Heart Fail; 2021 Aug; 8(4):2856-2865. PubMed ID: 33963812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serial scanning with
    Minutoli F; Di Bella G; Mazzeo A; Laudicella R; Gentile L; Russo M; Vita G; Baldari S
    J Nucl Cardiol; 2021 Oct; 28(5):1949-1957. PubMed ID: 31741327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
    Tini G; Sessarego E; Benenati S; Vianello PF; Musumeci B; Autore C; Canepa M
    Eur J Clin Invest; 2021 Dec; 51(12):e13665. PubMed ID: 34390490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study.
    Spielvogel CP; Haberl D; Mascherbauer K; Ning J; Kluge K; Traub-Weidinger T; Davies RH; Pierce I; Patel K; Nakuz T; Göllner A; Amereller D; Starace M; Monaci A; Weber M; Li X; Haug AR; Calabretta R; Ma X; Zhao M; Mascherbauer J; Kammerlander A; Hengstenberg C; Menezes LJ; Sciagra R; Treibel TA; Hacker M; Nitsche C
    Lancet Digit Health; 2024 Apr; 6(4):e251-e260. PubMed ID: 38519153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of Quantitative
    Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L
    Heart Lung Circ; 2022 Jun; 31(6):804-814. PubMed ID: 35181228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M
    J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers.
    Nagano N; Muranaka A; Nishikawa R; Ohwada W; Kouzu H; Kamiyama N; Fujito T; Mochizuki A; Nagahara D; Nakanishi M; Ohkubo Y; Hisahara S; Nakao S; Katoh N; Ishikawa A; Sakurai A; Yano T
    Int Heart J; 2022; 63(1):168-175. PubMed ID: 35095067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release.
    Sugiura K; Kozuki H; Ueba H; Kubo T; Ochi Y; Baba Y; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Wada N; Nakashima J; Murakami I; Ikeuchi M; Kitaoka H
    Circ Rep; 2021 May; 3(6):338-344. PubMed ID: 34136709
    [No Abstract]   [Full Text] [Related]  

  • 52. Early-phase myocardial uptake intensity of
    Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis.
    Park YJ; Lee J; Kim D; Choi JO; Kim SJ; Kim K; Choi JY
    BMC Med Imaging; 2023 Jul; 23(1):92. PubMed ID: 37460984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An optimized imaging protocol for [
    Schatka I; Bingel A; Schau F; Bluemel S; Messroghli DR; Frumkin D; Knebel F; Diekmann SM; Elsanhoury A; Tschöpe C; Hahn K; Amthauer H; Rogasch JMM; Wetz C
    J Nucl Cardiol; 2021 Dec; 28(6):2483-2496. PubMed ID: 34331215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [
    Minutoli F; Russo M; Di Bella G; Laudicella R; Spataro A; Vento A; Comis A; Gentile L; Mazzeo A; Vita G; Baldari S
    Eur Radiol; 2022 May; 32(5):3035-3044. PubMed ID: 35031838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
    Nitsche C; Aschauer S; Kammerlander AA; Schneider M; Poschner T; Duca F; Binder C; Koschutnik M; Stiftinger J; Goliasch G; Siller-Matula J; Winter MP; Anvari-Pirsch A; Andreas M; Geppert A; Beitzke D; Loewe C; Hacker M; Agis H; Kain R; Lang I; Bonderman D; Hengstenberg C; Mascherbauer J
    Eur J Heart Fail; 2020 Oct; 22(10):1852-1862. PubMed ID: 32078212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac scintigraphy and echocardiography assessment in the diagnosis of transthyretin cardiac amyloidosis.
    Del Carmen Mallón Araujo M; Casas EAJ; Casas CAJ; Monzonis MAM; Morell ÁR; Núñez VP
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):415-424. PubMed ID: 37943369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
    Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Value of
    Uusitalo V; Suomalainen O; Loimaala A; Mätzke S; Heliö T
    Heart Lung Circ; 2022 May; 31(5):629-637. PubMed ID: 35063379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis.
    Kristen AV; Haufe S; Schonland SO; Hegenbart U; Schnabel PA; Röcken C; Hardt S; Lohse P; Ho AD; Haberkorn U; Dengler TJ; Altland K; Katus HA
    Int J Cardiol; 2013 Apr; 164(2):179-84. PubMed ID: 21764155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.